NLR is a powerful predictor of outcomes in cardiovascular disease, cancer, infections, and autoimmune conditions. Elevated NLR indicates heightened inflammatory state and is associated with increased mortality risk. It's particularly useful for assessing disease severity and prognosis in critical illness, COVID-19, and cancer patients. Lower values suggest better immune balance and reduced systemic inflammation.
NLR is a powerful predictor of outcomes in cardiovascular disease, cancer, infections, and autoimmune conditions. Elevated NLR indicates heightened inflammatory state and is associated with increased mortality risk. It's particularly useful for assessing disease severity and prognosis in critical illness, COVID-19, and cancer patients. Lower values suggest better immune balance and reduced systemic inflammation.
The Neutrophil-to-Lymphocyte Ratio (NLR) is a simple, cost-effective marker of systemic inflammation and immune function. It reflects the balance between innate immunity (neutrophils) and adaptive immunity (lymphocytes).
Reference ranges may vary slightly between laboratories. The values below represent commonly accepted clinical ranges.
Ranges shown are general guidelines. Consult your provider for personalized interpretation.
| Biomarker | Reference range | Interpretation |
|---|---|---|
NLR (Neutrophil:Lymphocyte (Male — Standard) | 5–8 [pH] | Standard lab reference range |
NLR (Neutrophil:Lymphocyte (Female — Standard) | 5–8 [pH] | Standard lab reference range |
High NLR (Neutrophil:Lymphocyte levels above the standard range may indicate an underlying health condition that warrants further evaluation.
Low NLR (Neutrophil:Lymphocyte levels below the standard range may indicate an underlying health condition that warrants further evaluation.
The Neutrophil-to-Lymphocyte Ratio (NLR) is a simple, cost-effective marker of systemic inflammation and immune function. It reflects the balance between innate immunity (neutrophils) and adaptive immunity (lymphocytes).
Standard range men: 5–8 [pH]; women: 5–8 [pH]. Always interpret ranges in clinical context, not as a stand-alone diagnosis.
NLR is a powerful predictor of outcomes in cardiovascular disease, cancer, infections, and autoimmune conditions. Elevated NLR indicates heightened inflammatory state and is associated with increased mortality risk. It's particularly useful for assessing disease severity and prognosis in critical illness, COVID-19, and cancer patients. Lower values suggest better immune balance and reduced systemic inflammation.
High NLR: Often no direct symptoms, but associated conditions may cause fatigue, recurrent infections, poor wound healing, chronic pain, and general malaise. May indicate underlying inflammatory conditions or immune dysfunction.
High NLR: Acute infections, chronic inflammation, stress (physical or psychological), obesity, smoking, cardiovascular disease, cancer, autoimmune disorders, corticosteroid use, and severe illness. Low NLR: Generally favorable, but very low values may indicate immunocompromised states or bone marrow disorders.
NLR (Neutrophil:Lymphocyte can be ordered through Vitals Vault without a doctor referral, then completed at CLIA-certified Quest Diagnostics locations nationwide. After checkout, you receive clear draw instructions, digital requisition details, and a structured report that explains whether your result is in standard range, optimal range, or needs follow-up review.
Start by identifying the root cause, then use targeted nutrition, training, sleep, stress, and follow-up retesting to verify improvement. NLR (Neutrophil:Lymphocyte should be optimized with a personalized plan, not guesswork.
You should speak with a clinician if NLR (Neutrophil:Lymphocyte is significantly outside the reference range, trending in the wrong direction across repeat tests, or accompanied by symptoms like fatigue, chest discomfort, dizziness, weight change, or persistent inflammation signs. Immediate medical care is important for severe symptoms, not just abnormal numbers in isolation.
A practical retesting cadence for NLR (Neutrophil:Lymphocyte is every 8 to 12 weeks after major lifestyle, nutrition, or medication changes, and every 3 to 6 months for stable long-term tracking. Faster cadence is useful when values are clearly abnormal, while maintenance cadence helps confirm durability once results stabilize.
You can compare Essential ($99), Advanced ($199), and Max ($399) plans during checkout to confirm NLR (Neutrophil:Lymphocyte inclusion before purchasing. If NLR (Neutrophil:Lymphocyte is not in your selected tier, you can upgrade plans or add targeted testing so your panel matches your goals, symptoms, and retesting strategy.
NLR (Neutrophil:Lymphocyte is included in our comprehensive biomarker panels, processed at CLIA-certified Quest Diagnostics locations nationwide.
Foundation for a full basic health picture.
Deeper metabolic and nutritional insights.
Comprehensive testing for lifelong health.
Medical Disclaimer: This content is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with any questions about a medical condition or treatment. Do not disregard professional medical advice or delay seeking it because of information presented here.